#BEGIN_DRUGCARD DB04327

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
16038

# Chemical_Formula:
C41H83NO8P

# Chemical_IUPAC_Name:
(2-azaniumylethoxy)[(2S)-2,3-bis(octadecanoyloxy)propoxy]phosphinic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Phosphatidylethanolamine

# HET_ID:
PEE

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C41H82NO8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-40(43)47-37-39(38-49-51(45,46)48-36-35-42)50-41(44)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h39H,3-38,42H2,1-2H3,(H,45,46)/p+1/t39-/m0/s1

# InChI_Key:
InChIKey=LVNGJLRDBYCPGB-KDXMTYKHSA-O

# Indication:
Not Available

# KEGG_Compound_ID:
C00350

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4327

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
749.0734

# Molecular_Weight_Mono:
748.585630149

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1L8J

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
6.93

# Predicted_LogS:
-7.3

# Predicted_Water_Solubility:
4.03e-05 g/l

# Primary_Accession_No:
DB04327

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
17754130

# PubChem_Substance_ID:
46506543

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02690

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO[P@](O)(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:13 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
BA000019

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
alr3165

# Drug_Target_1_Gene_Sequence:
>786 bp
ATGAATTTGGAGAGTCTTTTACACTGGATTTATGTTGCGGGAATGACAATTGGTGCATTG
CACTTTTGGTCACTTAGTCGAAATCCGCGCGGTGTTCCCCAGTACGAATACCTTGTGGCG
ATGTTTATTCCCATTTGGTCGGGACTAGCCTATATGGCAATGGCAATAGACCAAGGTAAA
GTTGAAGCGGCTGGGCAAATTGCCCACTATGCCCGTTATATTGATTGGATGGTGACAACA
CCATTATTACTGCTATCTCTTTCTTGGACAGCGATGCAGTTTATCAAAAAAGATTGGACA
CTCATTGGTTTTTTGATGAGTACCCAGATAGTTGTAATTACCTCTGGGTTAATCGCAGAT
TTATCTGAGCGCGATTGGGTGAGATATCTATGGTATATCTGCGGGGTTTGCGCTTTTCTC
ATTATTCTTTGGGGTATTTGGAATCCATTGCGCGCCAAAACCAGAACTCAAAGTTCAGAA
CTAGCGAACTTATACGATAAGCTTGTTACTTATTTTACAGTGCTTTGGATAGGCTACCCA
ATAGTCTGGATTATTGGCCCTAGTGGTTTTGGCTGGATAAATCAAACTATAGATACATTT
TTGTTTTGTCTACTGCCCTTTTTCTCCAAGGTTGGATTTAGTTTTCTGGATTTACACGGC
TTACGTAATCTCAATGATTCCCGCCAAACTACTGGCGATCGCTTTGCGGAAAATACTTTA
CAGTTTGTAGAAAATATTACATTATTTGCTAACTCACGACGGCAACAATCACGCAGAAGA
GTTTGA

# Drug_Target_1_General_Function:
Involved in ion channel activity

# Drug_Target_1_General_References:
11724552	Einerwold J, Jaseja M, Hapner K, Webb B, Copie V: Solution structure of the carboxyl-terminal cysteine-rich domain of the VHv1.1 polydnaviral gene product: comparison with other cystine knot structural folds. Biochemistry. 2001 Dec 4;40(48):14404-12.
11759840	Kaneko T, Nakamura Y, Wolk CP, Kuritz T, Sasamoto S, Watanabe A, Iriguchi M, Ishikawa A, Kawashima K, Kimura T, Kishida Y, Kohara M, Matsumoto M, Matsuno A, Muraki A, Nakazaki N, Shimpo S, Sugimoto M, Takazawa M, Yamada M, Yasuda M, Tabata S: Complete genomic sequence of the filamentous nitrogen-fixing cyanobacterium Anabaena sp. strain PCC 7120. DNA Res. 2001 Oct 31;8(5):205-13; 227-53.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5631

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
30192

# Drug_Target_1_Name:
Bacteriorhodopsin

# Drug_Target_1_Number_of_Residues:
261

# Drug_Target_1_PDB_ID:
1XIO

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01036	Bac_rhodopsin

# Drug_Target_1_Protein_Sequence:
>Bacteriorhodopsin
MNLESLLHWIYVAGMTIGALHFWSLSRNPRGVPQYEYLVAMFIPIWSGLAYMAMAIDQGK
VEAAGQIAHYARYIDWMVTTPLLLLSLSWTAMQFIKKDWTLIGFLMSTQIVVITSGLIAD
LSERDWVRYLWYICGVCAFLIILWGIWNPLRAKTRTQSSELANLYDKLVTYFTVLWIGYP
IVWIIGPSGFGWINQTIDTFLFCLLPFFSKVGFSFLDLHGLRNLNDSRQTTGDRFAENTL
QFVENITLFANSRRQQSRRRV

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q8YSC4

# Drug_Target_1_SwissProt_Name:
Q8YSC4_NOSS1

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
9.03

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Membrane
single-pass type I membrane protein

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
PROCR

# Drug_Target_2_GenBank_ID_Gene:
L35545

# Drug_Target_2_GenBank_ID_Protein:
565268

# Drug_Target_2_GeneCard_ID:
PROCR

# Drug_Target_2_Gene_Name:
PROCR

# Drug_Target_2_Gene_Sequence:
>717 bp
ATGTTGACAACATTGCTGCCGATACTGCTGCTGTCTGGCTGGGCCTTTTGTAGCCAAGAC
GCCTCAGATGGCCTCCAAAGACTTCATATGCTCCAGATCTCCTACTTCCGCGACCCCTAT
CACGTGTGGTACCAGGGCAACGCGTCGCTGGGGGGACACCTAACGCACGTGCTGGAAGGC
CCAGACACCAACACCACGATCATTCAGCTGCAGCCCTTGCAGGAGCCCGAGAGCTGGGCG
CGCACGCAGAGTGGCCTGCAGTCCTACCTGCTCCAGTTCCACGGCCTCGTGCGCCTGGTG
CACCAGGAGCGGACCTTGGCCTTTCCTCTGACCATCCGCTGCTTCCTGGGCTGTGAGCTG
CCTCCCGAGGGCTCTAGAGCCCATGTCTTCTTCGAAGTGGCTGTGAATGGGAGCTCCTTT
GTGAGTTTCCGGCCGGAGAGAGCCTTGTGGCAGGCAGACACCCAGGTCACCTCCGGAGTG
GTCACCTTCACCCTGCAGCAGCTCAATGCCTACAACCGCACTCGGTATGAACTGCGGGAA
TTCCTGGAGGACACCTGTGTGCAGTATGTGCAGAAACATATTTCCGCGGAAAACACGAAA
GGGAGCCAAACAAGCCGCTCCTACACTTCGCTGGTCCTGGGCGTCCTGGTGGGCGGTTTC
ATCATTGCTGGTGTGGCTGTAGGCATCTTCCTGTGCACAGGTGGACGGCGATGTTAA

# Drug_Target_2_General_Function:
Involved in protein C biniding activity and blood coagulation

# Drug_Target_2_General_References:
10397730	Simmonds RE, Lane DA: Structural and functional implications of the intron/exon organization of the human endothelial cell protein C/activated protein C receptor (EPCR) gene: comparison with the structure of CD1/major histocompatibility complex alpha1 and alpha2 domains. Blood. 1999 Jul 15;94(2):632-41.
10570964	Hayashi T, Nakamura H, Okada A, Takebayashi S, Wakita T, Yuasa H, Okumura K, Suzuki K: Organization and chromosomal localization of the human endothelial protein C receptor gene. Gene. 1999 Oct 1;238(2):367-73.
10681599	Xu J, Qu D, Esmon NL, Esmon CT: Metalloproteolytic release of endothelial cell protein C receptor. J Biol Chem. 2000 Feb 25;275(8):6038-44.
11780052	Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J: The DNA sequence and comparative analysis of human chromosome 20. Nature. 2001 Dec 20-27;414(6866):865-71.
7929370	Fukudome K, Esmon CT: Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem. 1994 Oct 21;269(42):26486-91.

# Drug_Target_2_HGNC_ID:
HGNC:9452

# Drug_Target_2_HPRD_ID:
02801

# Drug_Target_2_ID:
2072

# Drug_Target_2_Locus:
20q11.2

# Drug_Target_2_Molecular_Weight:
26672

# Drug_Target_2_Name:
Endothelial protein C receptor

# Drug_Target_2_Number_of_Residues:
238

# Drug_Target_2_PDB_ID:
1LQV

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
Not Available

# Drug_Target_2_Protein_Sequence:
>Endothelial protein C receptor precursor
MLTTLLPILLLSGWAFCSQDASDGLQRLHMLQISYFRDPYHVWYQGNASLGGHLTHVLEG
PDTNTTIIQLQPLQEPESWARTQSGLQSYLLQFHGLVRLVHQERTLAFPLTIRCFLGCEL
PPEGSRAHVFFEVAVNGSSFVSFRPERALWQADTQVTSGVVTFTLQQLNAYNRTRYELRE
FLEDTCVQYVQKHISAENTKGSQTSRSYTSLVLGVLVGSFIIAGVAVGIFLCTGGRRC

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
1-17

# Drug_Target_2_Specific_Function:
Binds activated protein C. Enhances protein C activation by the thrombin-thrombomodulin complex; plays a role in the protein C pathway controlling blood coagulation

# Drug_Target_2_SwissProt_ID:
Q9UNN8

# Drug_Target_2_SwissProt_Name:
EPCR_HUMAN

# Drug_Target_2_Synonyms:
APC receptor
Activated protein C receptor
CD201 antigen
Endothelial cell protein C receptor
Endothelial protein C receptor precursor

# Drug_Target_2_Theoretical_pI:
7.20

# Drug_Target_2_Transmembrane_Regions:
211-231

#END_DRUGCARD DB04327
